抑制劑溶液
Metabolism
GPCR/GProtein
Neuroscience
Apoptosis
Chromatin/Epigenetic
TyrosineKinase/Adaptors
Microbiology/Virology
Angiogenesis
CellCycle/Checkpoint
Membranetransporter/Ionchannel
Immunology/Inflammation
DNADamage/DNARepair
Autophagy
CytoskeletalSignaling
StemCells
PI3K/Akt/mTORsignaling
Proteases/Proteasome
MAPK
JAK/STATsignaling
Endocrinology/Hormones
Others
更多…
| 產(chǎn)品編號 | 圖片 | 產(chǎn)品描述 | 分子式 | 加入購物車 | |
|---|---|---|---|---|---|
|
LY2857785，98% | C26H36N6O | |||
|
|
|||||
|
GSK2801，98% | C20H21NO4S | |||
|
|
|||||
|
GSK481，98% | C21H19N3O4 | |||
|
|
|||||
|
VR23，99% | C19H16ClN5O6S | |||
|
|
|||||
|
LJH685，99% | C22H21F2N3O | |||
|
|
|||||
|
MI-136，≥98% | C23H21F3N6S | |||
|
|
|||||
|
ARS-853，98% | C22H29ClN4O3 | |||
|
|
|||||
|
A-1210477，98% | C46H55N7O7S | |||
|
|
|||||
|
PD1-PDL1 inhibitor 1，99% | C29H33NO5 | |||
|
|
|||||
|
BMS-202，99% | C25H29N3O3 | |||
|
|
|||||
|
Ac-DEVD-CHO，95% | C20H30N4O11 | |||
|
|
|||||
|
Deracoxib，98% | C17H14F3N3O3S | |||
|
|
|||||
|
NQDI-1，98% | C19H13NO4 | |||
|
|
|||||
|
Voreloxin (Hydrochloride)，≥95% | C18H20ClN5O4S | |||
|
|
|||||
|
CCT007093，98% | C15H12OS2 | |||
|
|
|||||
|
DBeQ，98% | C22H20N4 | |||
|
|
|||||
|
C-DIM12，98% | C23H17ClN2 | |||
|
|
|||||
|
SHP099，98% | C16H19Cl2N5 | |||
|
|
|||||
|
CPI-360，98% | C25H31N3O4 | |||
|
|
|||||
|
FTI-277 (hydrochloride)，99% | C22H30ClN3O3S2 | |||
|
|
|||||
|
DEL-22379，99% | C26H28N4O3 | |||
|
|
|||||
|
AZD0156，99% | C26H31N5O3 | |||
|
|
|||||
